Crestwood Advisors Group’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-8,000
| Closed | -$208K | – | 269 |
|
2021
Q2 | $208K | Hold |
8,000
| – | – | 0.01% | 260 |
|
2021
Q1 | $253K | Sell |
8,000
-2,500
| -24% | -$79.1K | 0.01% | 235 |
|
2020
Q4 | $487K | Hold |
10,500
| – | – | 0.02% | 191 |
|
2020
Q3 | $346K | Hold |
10,500
| – | – | 0.01% | 192 |
|
2020
Q2 | $288K | Hold |
10,500
| – | – | 0.01% | 197 |
|
2020
Q1 | $314K | Hold |
10,500
| – | – | 0.02% | 181 |
|
2019
Q4 | $291K | Buy |
10,500
+500
| +5% | +$13.9K | 0.01% | 218 |
|
2019
Q3 | $182K | Hold |
10,000
| – | – | 0.01% | 245 |
|
2019
Q2 | $245K | Sell |
10,000
-2,500
| -20% | -$61.3K | 0.01% | 213 |
|
2019
Q1 | $119K | Hold |
12,500
| – | – | 0.01% | 171 |
|
2018
Q4 | $111K | Hold |
12,500
| – | – | 0.01% | 154 |
|
2018
Q3 | $141K | Hold |
12,500
| – | – | 0.01% | 164 |
|
2018
Q2 | $188K | Hold |
12,500
| – | – | 0.01% | 165 |
|
2018
Q1 | $211K | Hold |
12,500
| – | – | 0.02% | 158 |
|
2017
Q4 | $100K | Hold |
12,500
| – | – | 0.01% | 185 |
|
2017
Q3 | $97K | Hold |
12,500
| – | – | 0.01% | 157 |
|
2017
Q2 | $72K | Hold |
12,500
| – | – | 0.01% | 150 |
|
2017
Q1 | $77K | Hold |
12,500
| – | – | 0.01% | 209 |
|
2016
Q4 | $87K | Buy |
+12,500
| New | +$87K | 0.01% | 159 |
|